Bill

Bill > HF105


IA HF105

IA HF105
A bill for an act relating to the definition of medical cannabidiol.(See HF 950.)


summary

Introduced
01/22/2025
In Committee
01/22/2025
Crossed Over
Passed
Dead

Introduced Session

91st General Assembly

Bill Summary

This bill relates to the medical cannabidiol program. The bill changes the definition of “medical cannabidiol” to include specific forms of oral, topical, and inhalable cannabis.

AI Summary

This bill modifies the legal definition of "medical cannabidiol" in Iowa's medical cannabis program to expand the allowable forms of cannabis that can be used for medical purposes. Specifically, the bill broadens the definition to explicitly include three main categories of medical cannabis delivery methods: oral forms (such as tablets, capsules, liquids, tinctures, and sublingual preparations), topical forms (including gels, ointments, creams, lotions, and transdermal patches), and inhaled forms (limited to nebulizable inhalable cannabis, vaporizable dried raw cannabis, and other vaporizable cannabis forms). By providing this detailed and comprehensive list of acceptable medical cannabis formats, the bill aims to give patients and healthcare providers more flexibility in how medical cannabidiol can be administered, potentially increasing accessibility and treatment options for individuals who may benefit from medical cannabis. The bill represents an update to the existing medical cannabidiol statute, reflecting an evolving understanding of cannabis as a medical treatment and potential therapeutic option.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Committee report approving bill, renumbered as HF 950. (on 03/12/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...